# VASOPRESSIN
> **ANDA213206** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2023-05-26
## Drug
- **FDA Application Number:** ANDA213206
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VASOPRESSIN
- **Generic name:** VASOPRESSIN
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2023-05-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213206)
---
*AI Analytics · CC0 1.0*